Selective Use of Pulmonary Vasodilators in Patients with Fontan Physiology
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Interventional Cardiology"
DOI: 10.1155/2022/7602793
Abstract: Background Fontan-associated liver disease is a well-known sequela following the Fontan procedure for patients living with single-ventricle heart disease. Pulmonary vasodilators, such as phosphodiesterase type 5 inhibitors, have emerged as a potential therapeutic option for… read more here.
Keywords: patients fontan; pulmonary vasodilators; selective use; physiology ... See more keywords
Practice patterns of pulmonary hypertension secondary to left heart disease among pediatric pulmonary hypertension providers
Sign Up to like & getrecommendations! Published in 2021 at "Pulmonary Circulation"
DOI: 10.1177/2045894021991446
Abstract: Development of pulmonary hypertension (PH) in patients with left side heart disease (LHD) is a predictor of poor prognosis. The use of pulmonary vasodilators in PH associated with LHD (PH-LHD) is controversial. In this study,… read more here.
Keywords: heart; pulmonary hypertension; pulmonary vasodilators; use pulmonary ... See more keywords